Fused pyrazole derivatives as TGF-β signal transduction inhibitors for the treatment of fibrosis and neoplasms
US7368445B2 · kind B2 · utility
15Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 2005 |
| Grant date | May 6, 2008 |
| Priority date | — |
| Expiry date | Feb 16, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The disclosed invention is directed to compounds of the formula: Formula (I) and methods of using these compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.